首页> 美国卫生研究院文献>AAPS PharmSci >A Stability Analysis of a Modified Version of the Chi-Square Ratio Statistic: Implications for Equivalence Testing of Aerodynamic Particle Size Distribution
【2h】

A Stability Analysis of a Modified Version of the Chi-Square Ratio Statistic: Implications for Equivalence Testing of Aerodynamic Particle Size Distribution

机译:卡方比率统计量的修改版本的稳定性分析:对空气动力学粒度分布的等效检验的启示

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Demonstration of equivalence in aerodynamic particle size distribution (APSD; e.g., by comparing cascade impactor (CI) profiles) constitutes one of key in vitro tests for supporting bioequivalence between test (T) and reference (R) orally inhaled drug products (OIDPs). A chi-square ratio statistic (CSRS) was previously proposed for equivalence testing of CI profiles. However, it was reported that the CSRS could not consistently discriminate between equivalent and inequivalent CI profiles. The objective of the overall project was to develop a robust and sensitive methodology for assessing equivalence of APSD profiles of T and R OIDPs. We propose here a modified version of the CSRS (mCSRS) and evaluated systematically its behavior when T and R CI profiles were identical. Different scenarios comprising CI profiles with different number of deposition sites and shapes were generated by Monte-Carlo simulation. For each scenario, the mCSRS was applied to 20,000 independent sets of 30 T and 30 R CI profiles that were identical. Different metrics (including mean and median) of the distribution of 900 mCSRSs (30 T × 30 R) were then evaluated for their suitability as a test statistic (i.e., independent of the number of sites and shape of the CI profile) for APSD equivalence testing. The median of the distribution of 900 mCSRSs (MmCSRS) was one regardless of the number of sites and shape of the CI profile. Hence, the MmCSRS is a robust metric for CI profile equivalence testing when T and R CI profiles are identical and potentially useful for APSD equivalence testing.Electronic supplementary materialThe online version of this article (doi:10.1208/s12248-012-9410-1) contains supplementary material, which is available to authorized users.
机译:空气动力学粒度分布(APSD;例如,通过比较级联撞击物(CI)曲线)的等效性证明是支持试验(T)和参​​比(R)口服吸入药物产品(OIDP)之间生物等效性的关键体外试验之一。先前提出了卡方比率统计量(CSRS)用于CI配置文件的等效性测试。但是,据报道,CSRS无法始终如一地区分等效和不等效CI配置文件。整个项目的目的是开发一种鲁棒且灵敏的方法来评估T和R OIDP的APSD轮廓的等效性。我们在这里提出CSRS(mCSRS)的修改版本,并在T和R CI配置文件相同时系统评估其行为。通过蒙特卡洛模拟产生了包括具有不同数量的沉积部位和形状的CI分布的不同场景。对于每种情况,将mCSRS应用于20,000个相同的30 T和30 R CI轮廓的独立集合。然后评估900 mCSRS(30 T×30 R)分布的不同度量标准(包括均值和中位数)是否适合作为APSD等效性的测试统计数据(即与站点数和CI曲线形状无关)测试。 900个mCSRSs(MmCSRS)的分布中位数是1,与CI配置文件的位置和形状无关。因此,当T和R CI轮廓相同时,MmCSRS是CI轮廓等效测试的可靠指标,并且可能对APSD等效测试有用。电子补充材料本文的在线版本(doi:10.1208 / s12248-012-9410-1)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号